Home › Occupations › Bioengineers and Biomedical Engineers › Austin, TX
Bioengineers and Biomedical Engineers in Austin, TX: H-1B salaries
31 labor condition applications for this occupation with a work site in Austin, TX. Median offered base salary $101,500; middle half $82,072–$117,675.
By wage level
| Wage level | Median salary |
|---|---|
| Level I (entry) | $73,143 |
| Level II (qualified) | $105,680 |
| Level III (experienced) | $91,604 |
| Level IV (fully competent) | $140,000 |
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Employers
| Employer | LCAs | Median salary |
|---|---|---|
| The University of Texas at Austin | 12 | $80,080 |
| Paradromics, Inc. | 2 | $82,690 |
| Smith & Nephew, Inc. | 2 | $101,102 |
| Levels Health Inc. | 2 | $122,250 |
| Varian Medical Systems, Inc. | 2 | $142,011 |
| Blue Goji LLC | 2 | $105,000 |
| Neuralink Corp. | 2 | $100,517 |
| St. David's Medical Center | 1 | $83,928 |
| ClearCam Inc | 1 | $100,000 |
| Fresenius USA Marketing, Inc., a Fresenius Medical Care N.A. company | 1 | $103,000 |
| XBiotech USA Inc | 1 | $79,200 |
| Encore Medical LP | 1 | $150,000 |
| Abbott Laboratories | 1 | $140,000 |
| Cerevanta Inc. | 1 | $120,000 |
Job titles
- Research Associate4
- Senior Research Fellow3
- Postdoctoral Fellow3
- Research and Development Engineer2
- Manager, Design Quality2
- Assistant Professor2
- Medical Device Test Engineer1
- Manager of Asset Management1
- Quality Assurance Engineer II - KBGFJG107966-51
- R&D Engineer1
- R&D Portfolio Manager1
- Data Analyst1
- Biomechanical Data Analyst1
- Clinical Research Associate1
- Augmented Reality Senior Software Engineer1
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).